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     BSTRACT
Given the risks associated with antimicrobial resistance and its link with antimicrobial use,  
available data on antimicrobial use in the Belgian pig, broiler and veal calf production were 
compared. Allowing for comparison of the data available from three peer-reviewed scientific 
articles, the unit of measurement for antimicrobial use was the Treatment Incidence (TI), defined 
as the number of animals per 1000 treated daily with one ‘defined’ (DDDA) or ‘used daily dose 
animal’ (UDDA). Moreover, extrapolation of farm-level data to national-level data was attempted 
according to the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) 
methodology, to estimate the amount of antimicrobials used in Belgium per species. Although, 
among the three species, the highest TI was observed in veal calves (TIDDDA=414, TIUDDA=379), 
based on the extrapolation, it was estimated that most antimicrobials were administered to 
pigs (159.4 tons). Thus, the most rapid decline in the total use could potentially be achieved by 
targeting the pig sector. During the process of data collection for comparison and calculation, it 
became obvious that there is a need for harmonized monitoring programs.
SAMENVATTING
Het voorkomen van resistentie tegen antimicrobiële middelen houdt tal van risico’s in. Bovendien is 
er een link tussen het voorkomen van resistentie tegen antimicrobiële middelen en het gebruik van deze 
middelen. Het doel van deze studie is de beschikbare data over het gebruik van antimicrobiële middelen 
in de Belgische varkens-, vleeskuikens- en vleeskalversector te vergelijken. Om de beschikbare data 
van drie peer-reviewed, wetenschappelijke artikelen te kunnen vergelijken, werd het gebruik uitgedrukt 
in behandelingsincidenties (BI), gedefinieerd als het dagelijks aantal behandelde dieren per 1000 
dieren met 1 ‘defined’ (DDDA) of ‘used daily dose animal’ (UDDA). Daarnaast werd getracht de data 
over het gebruik op bedrijfsniveau te extrapoleren naar het gebruik op nationaal niveau op basis van 
de methodologie van de European Surveillance of Veterinary Antimicrobial Consumption (ESVAC). 
Zo werd een schatting beoogd van de totale hoeveelheid antimicrobiële middelen die gebruikt worden 
in België per diersector. Voor de drie sectoren werd de hoogste behandelingsincidentie waargenomen 
in de vleeskalversector (TIDDDA=414, TIUDDA=379). Bij de schatting, gebaseerd op extrapolatie, 
werd echter verondersteld dat de grootste hoeveelheid antimicrobiële middelen toegediend werden 
aan varkens (159.4 ton). De snelste daling in de totale hoeveelheid antimicrobiële middelen kan dus 
wellicht bereikt worden door middel van acties in de varkenssector. Tijdens het collecteren van de 
data om berekeningen en vergelijkingen voor deze studie mogelijk te maken, werd het duidelijk dat 
er dringend nood is aan geharmoniseerde monitoringsprogramma’s.
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INTRODUCTION
The benefits of antimicrobials hardly need to be 
reiterated. Since their introduction, they have revo- 
lutionized the approach to the treatment, control 
and prevention of human and animal infections, and 
have contributed to major advances, ranging from 
increased disease treatment and life expectancy to 
intensified modern food production. However, for 
many years, antimicrobials have been prescribed 
pointlessly and have often been used with an impru-
dent  prodigality.  In animal production, they used to 
be added to feed for growth promotion (banned in 
Europe since 2006) (Anonymous, 2005). They have 
often been administered unnecessarily or overused 
especially in group treatments, which are generally 
preferred over  individual treatment due to their eas-
ier application. Antimicrobials have also been pur-
chased and used as an easier and cheaper solution to 
prevent or treat conditions, instead of investments in 
infrastructure or disinfection of the farm. Inevitably, 
their use has resulted in a decreasing effectiveness 
in treating common infections and the emergence of 
multi-resistant strains of bacteria, such as methicillin- 
resistant Staphylococcus aureus (MRSA) and ex-
tended-spectrum beta-lactamase producing Entero-
bacteriaceae (ESBL) (Anonymous, 2014a).
Evidence is mounting that much of the antimicro-
bial resistance problem is rooted in the inappropri-
ate and excessive use of antimicrobial agents. This 
link between antimicrobial use and the emergence 
of resistance can be demonstrated at different levels, 
including the in vitro level, at which mutations have 
been observed to occur in genes of Salmonella typhi-
murium experimental mutants, leading to an increase 
of the minimum inhibitory concentration (MIC) of 
the antimicrobial and confirming resistance (Giraud 
et al., 1999; Cloeckaert and Chaslus-Dancla, 2001); 
the individual animal level, at which Berge et al. 
(2005) observed a shift to increasingly multiple re-
sistant fecal E. coli of feedlot steers in response to 
florfenicol treatment; and the farm, at which higher 
levels of resistance at group level are related to in-
creased antimicrobial usage (Dewulf et al., 2007; 
Costa et al., 2008; Persoons et al., 2010). The link be-
tween use and resistance can also be shown at the an-
imal sector level, at which Casteleyn et al. (2007) ob-
served that the animal sectors characterized by a high 
administration of antimicrobials, i.e. poultry and pig 
sector, demonstrate higher levels of resistant E. coli 
than dairy cattle and wild hares; and the country lev-
el, at which Chantziaras et al. (2013) clearly demon-
strated that in countries with high antimicro- bial us-
age, higher levels of resistance are also observed in 
indicator bacteria. 
The far-reaching burden of antimicrobial resis-
tance, both from a human health and veterinary per-
spective, could be summarized as different levels of 
therapeutic and prophylactic failure, coupled with 
an increase of treatment costs for resistant infections 
(Laxminarayan, 2013). Consequently, a global con-
cern for resistance has arisen. The 2013 World Eco-
nomic Forum highlighted antimicrobial resistance 
as a major global risk with the ability to destabi-
lize health systems (Anonymous, 2013c). Within the 
same framework, the European Council called upon 
the member states to strengthen surveillance systems 
and improve data quality regarding the resistance and 
use of antimicrobials in human and veterinary medi-
cine (Anonymous, 2008a; Anonymous, 2012b).
Given the risks associated with antimicrobial 
resistance, the possible transmission pathways of 
resistant bacteria between animals and humans, e.g. 
via direct contact, food or environment, (Wooldridge, 
2012) and the overwhelming evidence that antibiotic 
use has been a powerful selector of resistance (Acar, 
and Moulin 2012; Chantziaras et al., 2013), it is 
crucial that the levels of antimicrobial consumption 
in animals are monitored for the animal species and 
at the national level. Besides, the quantification of 
antimicrobial use is currently performed at a European 
level, at which consumption data of antimicrobials in 
veterinary medicine are collected from the member 
states by the European Medicines Agency (EMA) 
in the framework of the European Surveillance of 
Veterinary Antimicrobial Consumption (ESVAC) 
project.
With a view to contributing to the above cause, 
this study aims to: (1) give an overview of the anti- 
microbial consumption in veterinary medicine in 
Belgium in recent years, overall and per sector, i.e. 
pigs, broilers, veal calves. Additionally, the type of 
antimicrobial agents used, their administration routes 
and whether they are over or under-dosed are also in 
focus; (2) make comparisons regarding antimicrobial 
consumption among the aforementioned animal sec-
tors and over time, based on the data selected and de-
scribed to address aim (1); (3) attempt to extrapolate 
farm-level data to national-level data of antimicrobials 
consumed by the Belgian pig, broiler and veal calf 
populations, in order to make estimations of the total 
use per sector in the country.
MATERIALS AND METHODS
Selection of scientific data sources
The data to address the objectives of this review 
were retrieved from the 2012 Belgian Veterinary Sur-
veillance of Antimicrobial Consumption (BelVet-
SAC)  report (Anonymous, 2012a), as well as from 
the study results of Callens et al. (2012), Pardon et al. 
(2012) and Persoons et al. (2012) for pigs, veal calves 
and broilers, respectively. The aforementioned report 
and scientific articles were considered representative 
to provide recent and relevant data on antimicrobial 
consumption in three important sectors of intensive 
livestock production in Belgium. 
In detail, the data provided by the 2012 BelVet-
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SAC report consist of all veterinary antimicrobials 
sold to pharmacists and veterinarians in Belgium, i.e. 
antimicrobial pharmaceuticals, and of antimicrobial 
premixes incorporated in medicated feed, between 
2007 and 2012. Likewise to the 2007-2009, 2010 and 
2011 reports, in the 2012 BelVet-SAC report, yearly 
consumption figures of antimicrobials and antimicro-
bial premixes (mg) are put versus the animal produc-
tion expressed as produced biomass (kg), according 
to the methodology described by Grave et al. (2010). 
The biomass is calculated as the sum of the amount 
of pork, beef and poultry meat produced in a year, 
plus the number of dairy cattle in Belgium, times 
500kg of metabolic weight per head. Although hors-
es, small ruminants, companion animals and rabbits 
(accounting for 6% of the total biomass) are covered 
in the collected data on antimicrobial use, they are 
not taken into account when calculating the biomass.
Regarding the specific individual species, i.e. 
pigs, veal calves, broilers, the articles selected (Cal-
lens et  al., 2012; Pardon et al., 2012; Persoons et al., 
2012) all used similar methodologies and expressed 
antibiotic use based on the same quantitative mea-
surement (the treatment incidence), which allows 
to compare results and draw conclusions. The treat-
ment incidence (TI) is defined as the number of ani-
mals per 1000 that are treated daily with one defined 
daily dose animal (DDDA) or used daily dose ani-
mal (UDDA). The DDDA corresponds to the average 
maintenance dose for the main indication in a speci-
fied species, while the UDDA reflects the dose actu-
ally administered to the animal by the producer or the 
veterinarian. 
The following formulas were used to calculate the 
TIs:
TIDDA= [total amount of drug administered (mg)] / 
[DDDA(mg/kg) × number of days at risk × kg of ani-
mal] × 1000
TIUDDA= [total amount of drug administered (mg)] 
/ [UDDA (mg/kg) × number of days at risk × kg of 
animal] × 1000 (Timmerman et al., 2006).
The data retrieved from Callens et al. (2012) con-
cern the prophylactic, i.e. the administration of an 
antimicrobial drug to healthy animals known to be 
at risk, and metaphylactic, i.e. the administration of 
antimicrobial drugs to clinically healthy animals in 
contact with animals with detected clinical signs, use 
of antimicrobials in group treatments between birth 
and slaughter, i.e. one production cycle, in Belgian 
pig herds, and were collected retrospectively from 50 
closed and semi-closed herds between January and 
October 2010. Data concerning sows were not in-
cluded. Persoons et al. (2012) collected antimicrobial 
consumption records from 32 randomly selected Bel-
gian broiler farms during two non-consecutive pro-
duction cycles, in 2007 and 2008, while Pardon et al. 
(2012) collected prospective antimicrobial consump-
tion data from 15 white veal farms in Belgium, be-
tween 2007 and 2009, with the complete production 
cycle as the study period.
Data used
The data of interest to address the aims of this 
article retrieved from the studies by Callens et al. 
(2012), Pardon et al. (2012), Persoons et al. (2012) 
and the BelVet-SAC report (2012a) include: quanti-
tative information on the consumption of antimicro-
bials for veterinary use in Belgium, overall and per 
species, i.e. pigs, veal calves, broilers, expressed in 
tons of active substance per year, in mg of active sub-
stance used per kg of biomass produced or as treat-
ment incidence; quantitative information on the rela-
tive use of the different active substances, overall and 
per species; and qualitative information regarding the 
administration route and the correctness of dosing, 
according to the Summary of Product Characteristics 
(SPC). 
Extrapolation of farm-level data to the national 
level
Based on the data of Callens et al. (2012), 
Pardon et al. (2012) and Persoons et al. (2012), an 
extrapolation to the national level of antimicrobial 
consumption by the respective animal sectors was 
attempted. The objective of this extrapolation was 
to provide estimates on antimicrobial consumption 
for the actual species at the national level, and was 
made according to the methodology described at the 
ESVAC scientific guidelines paper on the collection of 
reliable and standardized data on the consumption of 
antimicrobial agents by animal species (Anonymous, 
2013a), which can be summarized as follows:
Amount of antimicrobials administered natio- 
nally, per species (tons)
= amount of antimicrobials used in the studied 
population (tons)
× [whole national population (number of ani-
mals)]/[studied population (number of animals)]
To calculate the total amount of antimicrobials ad-
ministered in pigs on an annual basis, available data 
on the total number of pigs slaughtered in Belgium 
in 2008 were used (Anonymous, 2014b). To calcu-
late the same value for broilers, available data for 
the total number of broilers slaughtered in Belgium 
in 2008 were considered (Anonymous, 2012c). As 
for veal calves, the average total number of animals 
slaughtered in Belgium between 2009-2012 was used 
(Anonymous, 2014c).
RESULTS
BelVet-SAC national results 
According to the BelVet-SAC report, in 2012, the 
total national consumption of antimicrobial pharma-
ceuticals for farm and companion animals in Bel-
gium reached 222.5 tons of active substance, while 
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the consumption of antimicrobial premixes incor-
porated in medicated feed was 55.4 tons. When the 
above figures were put versus the amount of biomass 
produced in the same year (calculated as 2.033.855 
tons), this gave 109.39 mg of active substance/kg 
biomass for antimicrobial pharmaceuticals used and 
27.22 mg/kg for medicated premixes.
Compared to 2011, a substantial decrease of 7.2% 
in the total veterinary consumption of antimicro- 
bials was observed in Belgium in 2012 (Anonymous, 
2012a). During that year, the consumption of anti-
microbial pharmaceuticals decreased by 7.9%, while 
the use of antimicrobial premixes decreased by 3.5%. 
Looking further backward, a promising decreasing 
trend of 20.3% in the total consumption can be ob-
served between 2007 and 2012, when the first Bel-
Vet-SAC data collection procedures were started 
(Figure 1). 
The antimicrobial compounds most frequently 
used in 2012 were the combination of sulphonamides 
and trimethoprim, followed by the antimicrobial 
classes of penicillins and tetracyclines (Table 1). 
Compared to 2011, the use of the last two was re-
duced by 6.1% and 13% respectively, in 2012, where-
as the use of sulphonamides and trimethoprimwas in-
creased by 1.6%. 
Compared to 2011, the consumption of cephalo-
sporins (especially of the third  and fourth genera-
tion) and quinolones (especially the fluoroquino-
lones) was increased in 2012 (2.7% and 3.1%, re-
spectively). Even though this increase was limited 
in absolute values of active substance, it is of con-
cern since these groups of antimicrobials are listed as 
critically important for resistance selection in both 
humans and animals by the World Health Organiza-
tion (WHO) (Anonymous, 2011) and the World Or-
ganization for Animal Health (Anonymous, 2008b). 
Moreover, this trend has been observed for a second 
year in a row.
Antimicrobial use in Belgian pig farms
Callens et al. (2012) quantified the antimicro- 
bial drug consumption in Belgian fattening pig farms 
expressed in TI. The average values for TIDDDA and 
TIUDDA were 235.8 and 200.7. This means that on 
average, 235 pigs were treated with one DDDA and 
200 were treated with one UDDA. These values were 
higher than the values calculated by Timmerman et 
al. (2006), which were based on data collected in the 
same way in 2003 (178.1 and 170.3, respectively). In 
particular, TIUDDA increased by almost 18%. It should 
also be mentioned that a large variation among the 
treatment incidences of different herds has been ob-
served (Callens et al., 2012) (Figure 2).
The oral and injectable antimicrobials most fre-
quently used in pig production are shown in Table 1. 
They are expressed as a percentage of the total 
amount of antimicrobials used. Callens et al. (2012) 
found that the majority of group treatments are ad-
ministered during the farrowing and battery period, 
while much less treatments are administered during 
the fattening period. On average, 80% of antimicro-
bial treatments in pig production are administered 
before the age of ten weeks. Callens et al. (2012) 
also concluded that prophylactic antimicrobial group 
treatment was applied in 93% of all group treatments, 
whereas metaphylactic or curative treatments were 
applied in only 7% of the cases. 
The main reasons for antimicrobial use include di-
Figure 1. Total national consumption of antimicrobial 
compounds for veterinary use in Belgium from 2007 till 
2012 (tons of active substance) (Anonymous, 2012a).
Table 1. Antimicrobial compounds most frequently used in Belgium, overall (Anonymous, 2012a) and per livestock 
species (% in the total of antimicrobials used) (Callens et al., 2012; Pardon et al., 2012; Persoons et al., 2012). For pigs, 
figures are given for both oral and injectable compounds. 
                            Pigs  Broilers White veal calves Overall
Oral Injectable
   
Colistin (30.7%) Tulathromycin (45%) Amoxicillin (43%) Oxytetracycline (23.7%) Trimethoprim/sulpho-
    namides (31.1%)
Amoxicillin (30%) Ceftiofur LAa (40.1%) Tylosin (30%) Amoxicillin (18.5%) Penicillins (29.7%)
Trimethoprim/sulpho- Amoxicillin (8.4%) Trimethoprim/sulpho- Tylosin (17.2%) Tetracyclins (26.3%)
namides (13.1%)  namides (18%)
a: LA, long lasting
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gestive disorders and streptococcal infections in pig-
lets, as well as respiratory problems during the sec-
ond half of the battery period (Callens et al., 2012). 
In the study, group treatments were primarily admin-
istered via the parenteral route in sucking piglets and 
orally in piglets after weaning via the feed or drink-
ing water. Generally, oral treatments were more com-
mon than injectable ones (TIUDDA, oral =176.5, while 
TIUDDA, injectable, =24.2). Injectable treatments were fre-
quently overdosed (79.5% overdosed, 8.2% correctly 
dosed, 12.3% underdosed), while oral administra-
tions were often underdosed (47.3% underdosed, 
23.3% correctly dosed, 29.4% overdosed).
Based on the data of Callens et al. (2012), the 
extrapolated amount of antimicrobials consumed by 
the national pig population is estimated to be 159.4 
tons. It should be noted that this value refers to 
(prophylactic and metaphylactic) group treatments in 
fattening pigs only, and does not include therapeutic 
use nor antimicrobials used in sows. 
Antimicrobial use in Belgian broiler farms
Persoons et al. (2012) estimates that the average 
treatment incidences based on the defined daily dose 
(TIDDDA) and the actual dose applied (TIUDDA) equal 
131.8 and 121.4 daily treated broilers per 1000, re-
spectively. Likewise to pig farms, considerable 
variations exist in antimicrobial use between farms 
(Figure 3). Twenty two percent (7/32) of the farms 
in the study managed to grow broilers without us-
ing antimicrobials in both of the production rounds 
monitored. In the treated farms, antimicrobials were 
used in 75% of the production cycles and were al-
most exclusively administered via drinking water in 
group treatments. Individual treatment in poultry is 
practically difficult and therefore seldom performed. 
The antimicrobials most frequently used in broiler 
production are given in Table 1. In particular, amoxi-
cillin and tylosin were administered in more than half 
of the treatments examined by Persoons et al. (2012). 
They are both classified as critically important anti-
microbials (class I) for both human and animal health 
by WHO (Anonymous, 2011) and OIE (Anonymous, 
2008).
The main reasons for antimicrobial administration 
in broilers are necrotic enteritis and dysbacteriosis, 
followed by feet disorders, coccidiosis and respira-
tory problems (Persoons, 2012). In the average flock 
of the study, most of the antimicrobials administered 
were usually dosed within the range of correct dos-
ing. However, tylosin was usually underdosed, while 
amoxicillin and trimethoprim-sulphonamide were 
slightly overdosed.
According to the ESVAC methodology and based 
on the data of Persoons et al. (2012), the annual 
amount of antimicrobials consumed by the Belgian 
broiler population is estimated to be 26.5 tons. 
Antimicrobial use in Belgian veal calf farms
Pardon et al. (2012) calculated the TI, based on 
the DDDA (TIDDDA) and the UDDA (TIUDDA) and con-
sidering the actual live weight of the animals, as 414 
and 379 calves treated with one daily dose of antimi-
crobial agents per 1000 animals, respectively. Also 
Figure 2. Treatment incidence based on the “used daily dose animal” (UDDA) and the “defined daily dose animal” 
(DDDA) in 50 pig farms in Belgium (Callens et al., 2012). 
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in the veal calf sector, a relatively large variation 
between farms regarding antimicrobial use was ob-
served (Figure 4). 
Table 1 includes the most frequently used antimi-
crobials for group treatments of white veal calves, 
which are classified as critically important for public 
health (Pardon et al., 2012). Thirteen percent of the 
antimicrobial group treatments were administered 
prophylactically and 87% metaphylactically. The 
main indication for administration was respiratory 
disease (53%). Other common indications were ar-
rival prophylaxis (13%), diarrhea (12%) and dysbac-
teriosis (12%). Group treatments were used in 97.9% 
of the cases and were all orally administered in milk.
The antimicrobials were mostly overdosed 
(TIUDDA < TIDDDA). However, likewise to pigs, over 
40% of group treatments were underdosed. Espe-
cially oxytetracycline and tylosin, when used to treat 
dysbacteriosis, were systematically and significantly 
underdosed. 
The data of Pardon et al. (2012) were considered 
representative to be used for extrapolation to the natio- 
nal level, based on which the annual antimicrobial 
consumption in white veal calves is estimated to be 
25.2 tons. 
Figure 3. Treatment incidence based on “used daily dose animal” (UDDA) and “defined daily dose animal” (DDDA) 
in 32 broiler farms in Belgium in two non-consecutive production cycles (Persoons et al., 2012). 
Figure 4. Treatment incidence based on “used daily dose animal” (UDDA) and “defined daily dose animal” (DDDA)
in 15 white veal calf farms in Belgium (Pardon et al., 2012).
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DISCUSSION
When it comes to interpreting antimicrobial con-
sumption data, the unit of measurement as well as the 
use of standard measurement units for time at risk 
and average weight of animals at time of treatment, 
are crucial. The scientific data sources selected for 
this study provide data on the consumption of anti-
microbials for veterinary use in Belgium, and are ex-
pressed in different ways. 
Firstly, the BelVet-SAC report provides overall 
data for farm and companion animals expressed in 
tons of active substance per year and in mg of ac-
tive substance used per kg of biomass produced. 
This approach is similar to the one used by the Euro- 
pean Medicines Agency (EMA) in the ESVAC re-
ports, where consumption data from EU countries are 
presented in mg of active substance per population 
correction unit (PCU), a unit of quantification of ani-
mal production comparable to the biomass. Although 
crude and not detailed enough for between-species 
differentiation, the BelVet-SAC report data provide 
an interesting insight into the evolution of the total 
antimicrobial use of the past years. 
In contrast to the 2012 BelVet-SAC report, the se-
lected scientific articles provide data per species, i.e. 
pigs, veal calves, broilers, quantified as treatment in-
cidence (TI) of antimicrobials, at the end-user level. 
Being based on a sample of herds, these studies do 
not give a complete overview of the total antimicro- 
bial consumption in Belgium as the BelVet-SAC re-
port does. Additionally, the sampled farms were par-
tially selected according to the willingness of the 
farmers to cooperate. Hence, there is an inherent risk 
of bias that should be taken into account. However, 
the sampled farms provide an insight into the anti-
microbial use per species, which is detailed in terms 
of including data on the microbial agents used, their 
dosages, indications for administration, and also 
show a wide, and skewed distribution in use between 
herds and production types. This signifies that some 
herds manage to grow their animals without using 
antimicrobials, while others do not.
Since all three articles used a similar methodology, 
i.e. TI, the data they provide can be compared, despite 
referring to different sectors, sample sizes and years 
of data collection. Based on a general comparison of 
the TIs estimated for pigs, broilers and veal calves, 
it was observed that antimicrobial use is more fre-
quent in veal calves (TIDDDA= 414.0, TIUDDA=379.0), 
followed by pigs (TIDDDA=235.8, TIUDDA=200.7) and 
broilers (TIDDDA= 131.8, TIUDDA=121.4) (Figure 5). 
The very high usage in veal calf production is most 
likely explained by the typical organization of the 
veal industry and more specifically, by the way veal 
calves are collected. Furthermore, it is known that the 
incidence of antimicrobial treatments in veal calves 
is much higher than in conventional dairy and beef 
cattle, 6.3 and 5.4 per 1000 cattle, respectively (Par-
don et al., 2012). 
From a methodological point of view, the use of 
TI as an indicator of antimicrobial consumption is 
more relevant in terms of estimating selection pres-
sure for antimicrobial resistance than the total weight 
of antimicrobials consumed. Moreover, this method 
overcomes the issue of differences in molecular 
weight between different antimicrobial products. If 
antimicrobial use is systematically quantified in the 
same way and converted to the same denominator, 
comparable data may be available and can then be 
used to follow up the amount of antimicrobials used 
in different sectors or farms and over time (Timmer-
man et al., 2006). Besides, in a European framework, 
an equivalent indicator to the TIs, i.e. the number of 
defined daily dose animals (DDDA) consumed by 
weight group/1000 animals produced or livestock/
year, is proposed by the EMA to be used in a stan-
dardized manner for reporting the consumption of an-
timicrobial agents by species (Anonymous, 2013a). 
At this point, it should be pointed out that the aver-
age animal weight at treatment used in the calcula-
tion of TI has a large influence on the obtained re-
sults. Therefore, this weight should always be exam-
Figure 5. Comparison of the treatment incidences 
among Belgian broilers, pigs and veal calves.
Figure 6. Left column: estimated amount in tons of 
antimicrobials used annually in Belgian pigs, broilers 
and veal calves at the national level, after extrapolating 
farm-level data from selected studies. Right column: to-
tal amount in tons of antimicrobials and medicated pre-
mixes used in Belgium in 2009 (Anonymous, 2012a).
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ined with caution to prevent over or underestimation 
of the TI. Although the use of actual weights of the 
animals at treatment is laborious, it provides more ac-
curate estimates of TIs.
The difference in methodologies does not allow 
for immediate comparisons between the BelVet-SAC 
report and the scientific articles. However, extrapo-
lation from the farm-level data to the national-level 
data was attempted, based on the methodology de-
scribed at the ESVAC scientific guidelines paper on 
the collection of reliable and standardized data on the 
consumption of antimicrobial agents by animal spe-
cies (Anonymous, 2013a). 
According to this extrapolation attempt, pigs 
(sows not included) consume most antimicrobials 
at the national level in Belgium, i. e. 159.40 tons 
annually, followed by broilers (26.53 tons) and white 
veal calves (25.18 tons), which, as already shown, 
have the highest TI. The relative contribution of the 
different animal species to the total use is shown in 
Figure 6, where the results are compared to the total 
use in 2009, the year considered as the most suitable 
in accordance with the years of data collections. It 
should be noted that this value remained almost con-
stant from 2008 till 2011 (Figure 1). According to the 
gathered data and estimations, the use of antimicro-
bials in pigs, broilers and veal calves corresponds to 
69.4% of the total use in Belgium. Yet, the extrapo-
lation and the relative contribution should be inter-
preted with caution and only be seen as indicative. 
Several sources of uncertainty are possible, which 
are related to the representativeness of the sampled 
herds and to the fact that treatments in sows and cu-
rative treatments were not taken into account at the 
pig herds. Hence, caution is urged in concluding that 
the difference between the two columns reflects the 
antimicrobial use in dairy and beef cattle, small rumi-
nants, horses, layers and companion animals.
Despite these calculations being rough due to the 
limited data available, it is important to attempt such 
extrapolations of data to the national level or even to 
the regional level, depending on the country. The re-
sults may prove useful, since they can provide esti-
mates on sales and consumption of antimicrobials at 
the species level, and possibly per weight category and 
production type, as well as on data pools for further 
(combined) analyses, e.g. ecological or economic 
analyses. Overall, they could be used to support the 
targeting of monitoring procedures and efforts to re-
duce antimicrobial usage. 
Regarding the antimicrobial compounds, those 
belonging to the WHO critically important list are 
frequently administered in all three species (Cal-
lens et al., 2012; Pardon et al., 2012; Persoons et al., 
2012). Despite the overall decrease in antimicrobial 
consumption in Belgium in recent years, the use of 
molecules of critical importance for human medicine 
has remarkably increased for a second year in a row.
In this study, a number of needs regarding antimi-
crobial consumption data and related practices were 
observed. A wide and more detailed data collection 
covering all production sectors is needed and is im-
portant for benchmarking, monitoring and analysis of 
trends. Additionally, it would be appropriate to use 
differentiating statistics per animal production sector 
when comparing different countries, where the type 
of production system may differ (intensive, exten-
sive). This monitoring work should be repeated every 
year in a harmonized manner, using the same quan-
tification units. In line with this,  scientific articles 
and reports, in which a more or less uniform metho-
do-logy is used, would allow broader and more accu-
rate comparisons, e.g. between countries. In addition, 
it seems that clear guidance on correct dosing needs 
to be provided on a regular basis to veterinarians, 
farmers and other stakeholders responsible for anti-
microbial administration to animals. 
According to the third ESVAC report of EMA 
for 2011, Belgium holds the sixth position in terms 
of sales volume of antimicrobials over 25 EU coun-
tries (Anonymous, 2013b). The previous year, Bel-
gium was in third place. Since there was virtually no 
change in use in Belgium between 2010 and 2011, 
the change in positioning is solely the result of the 
addition of new countries with a higher consump-
tion in the dataset, which had not provided data pre-
viously. Both places are high. For that reason, the re-
duction in the antimicrobial use observed by the Bel-
Vet-SAC in 2012 is hoped to be maintained (Anony-
mous, 2012a). This reduction in antimicrobial con-
sumption in Belgium (Anonymous, 2012a) and also 
in Europe (Anonymous, 2013b) over the last few 
years is a promising trend. However, this reduction 
should not be taken for granted and efforts should 
be continued towards this direction. At the Belgian 
level, the Centre of Knowledge for Antimicrobial 
Consumption and Resistance in Animals (AMCRA) 
aims to promote the prudent use of antimicrobials, 
and has produced a list of guidelines on responsible 
antimicrobial consumption, where the various anti-
microbial classes are differentiated in terms of im-
portance for public and animal health according to 
the WHO and OIE lists (Anonymous, 2011; Anony-
mous, 2014d). 
In other words, antimicrobials need to be used sus-
tainably. From a Belgian perspective and given that 
the use in the three major livestock species accounts 
for a large proportion of the total use, this could 
be translated to sector targeting actions. Besides, it 
has been shown here, that despite of the veal sector 
demonstrating the highest frequency in use per 
animal head, the pig sector demonstrates the 
highest consumption in absolute values at the 
national level (Figures 5 and 6). Simultaneously and 
next to this quantitative approach, it is very crucial 
that producers of smaller industries, e.g. the veal calf 
sector, embrace active responsibility in this global 
health issue, and that all sectors endorse antimicro-
bial stewardship. 
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Mededeling
WVPA België is een vereniging voor en door pluimveedierenartsen
WVPA België organiseert jaarlijks verschillende studienamiddagen omtrent problemen bij industrieel gehouden 
pluimvee. De thema’s van de studienamiddagen spelen in op de huidige problematiek in de pluimveesector en 
proberen tegemoet te komen aan de verwachtingen van de pluimveedierenarts. Het lidgeld bedraagt 50 euro voor 
individuele leden en 160 euro voor steunende leden.
Voor het academiejaar 2014-2015 zijn volgende activiteiten gepland: 
-	 IB-infecties in Europa
Studienamiddag zal plaats vinden op vrijdag 24 september 2014 op de Faculteit Diergeneeskunde te 
Merelbeke
-	 Studienamiddag over autovaccinatie (januari-februari 2015)
-	 Studienamiddag over ‘emerging diseases’ (9 april 2015)
-	 Studienamiddag over Pasteurella en Gallibacterium anatum (mei-juni 2015)
Meer informatie over het programma en lidgelden kan u vinden op de website www.wvpa.be
